Anagrelide is a drug used for the treatment of essential thrombocytosis (ET;
essential thrombocythemia), or overproduction of blood platelets. It also has been
Aug 5, 2015 ... Learn about the prescription medication Agrylin (Anagrelide), drug uses, dosage,
side effects, drug interactions, warnings, reviews and patient ...
Anagrelide is used to decrease the number of platelets (a type of blood cell that is
needed to control bleeding) in the blood of patients who have a bone marrow ...
Type, Small Molecule. Groups, Approved. Description. Anagrelide is a drug used
for the treatment of essential thrombocytosis (ET; essential thrombocythemia).
(anagrelide hydrochloride). Dosage Form: 0.5 mg capsules for oral
administration. Active Ingredient: AGRYLIN. ®. Capsules contain 0.5 mg of
anagrelide base ...
Medscape - Indication-specific dosing for Agrylin (anagrelide), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Anagrelide is used to decrease the risk of blood clots in patients who have
thrombocythemia (too many platelets in the blood). It works to decrease
production of ...
Consumer information about the medication ANAGRELIDE - ORAL (Agrylin),
includes side effects, drug interactions, recommended dosages, and storage ...
Jun 1, 2016 ... Anagrelide Hydrochloride oral capsule, Teva 0.5 mg, 100 ... Mylan
Pharmaceuticals discontinued anagrelide capsules in 2015. Teva cannot ...
Agrylin (anagrelide hydrochloride) 0.5 mg Capsules Drug Safety Labeling
Changes July 2015, October 2014, February 2014, July 2013, November 2011,